Linfoma difuso de células grandes B rectal en un paciente con colitis ulcerosa

Primary colorectal lymphoma is a rare form of presentation of gastrointestinal tract lymphomas. Inflammatory bowel disease and its treatment are risk factors for its development. We report a 47 years old male patient with Ulcerative Colitis of two years of evolution, treated initially with azathioprine and later on with infliximab. Due to a relapse in symptoms after the second dose of infliximab, a new coloncoscopy was performed showing a rectal ulcerative lesion, corresponding to a large cell Non-Hodgkin's Lymphoma. The patient was successfully treated with RCHOP chemotherapy (Rituximab cyclophosphamide doxorubicin vincristine prednisone). He is currently in disease remission.

[1]  Sang‐wook Lee,et al.  Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients , 2017, Blood research.

[2]  J. Gisbert,et al.  Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry , 2017, The American Journal of Gastroenterology.

[3]  Z. Ge,et al.  Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma , 2016, World Journal of Surgical Oncology.

[4]  D. Winter,et al.  Primary colorectal lymphoma - A single centre experience. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[5]  K. Van Steen,et al.  Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodies , 2014, Pharmacoepidemiology and drug safety.

[6]  W. Sandborn,et al.  Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry , 2014, The American Journal of Gastroenterology.

[7]  L. Bazzano,et al.  Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. , 2013, Gastroenterology.

[8]  P. Lakatos,et al.  The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. , 2013, Journal of Crohn's & colitis.

[9]  A. Ananthakrishnan,et al.  Effects of cancer treatment on inflammatory bowel disease remission and reactivation. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  B. Ramakrishna,et al.  Gastrointestinal lymphomas: pattern of distribution and histological subtypes: 10 years experience in a tertiary centre in South India. , 2011, Indian journal of pathology & microbiology.

[11]  Guangyao Wu,et al.  Primary gastrointestinal lymphoma. , 2011, World journal of gastroenterology.

[12]  Jinny Park,et al.  Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. , 2011, Blood.

[13]  J. Stockman Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2011 .

[14]  J. West,et al.  Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study , 2010, The American Journal of Gastroenterology.

[15]  B. Sands,et al.  Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  M. Czuczman,et al.  The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum. , 2007, American journal of surgery.

[17]  J. Askling,et al.  Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  M. Wong,et al.  Primary colorectal lymphomas , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  A. Iliadou,et al.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[20]  Z. Barta,et al.  Pulse cyclophosphamide therapy for inflammatory bowel disease. , 2006, World journal of gastroenterology.

[21]  F. Quayle,et al.  Colorectal lymphoma. , 2006, Clinics in colon and rectal surgery.

[22]  J. Kim,et al.  Primary Colon Lymphoma in Korea: A KASID (Korean Association for the Study of Intestinal Diseases) Study , 2005, Digestive Diseases and Sciences.

[23]  C. Brensinger,et al.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.

[24]  Takayuki Takahashi,et al.  Association of intestinal malignant lymphoma and ulcerative colitis. , 2003, Internal medicine.

[25]  R. Cartwright,et al.  Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. , 2002, The hematology journal : the official journal of the European Haematology Association.

[26]  H. Lee,et al.  Primary colorectal lymphoma: spectrum of imaging findings with pathologic correlation , 2002, European Radiology.

[27]  A. Zinsmeister,et al.  Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. , 2002, Gastroenterology.

[28]  N. Willich,et al.  Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Y. Wang,et al.  Colonoscopic manifestations of primary colorectal lymphoma. , 2001, Endoscopy.

[30]  C. Copie-Bergman,et al.  Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. , 1997, The Journal of pathology.

[31]  M. Larson,et al.  Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy. , 1994, Journal of clinical gastroenterology.

[32]  G. Dodd,et al.  Lymphoma of the hollow abdominal viscera. , 1990, Radiologic clinics of North America.

[33]  N. Shepherd,et al.  Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations , 1988, Histopathology.

[34]  J. Berg,et al.  Occurrence and prognosis of extranodal lymphomas , 1972, Cancer.